CT联合MRI用于子宫内膜癌分期诊断的价值分析与效果观察

Value Analysis and Efficacy Observation of CT in Combination with MRI on Staging Diagnosis of Endometrial Carcinoma

目的探讨CT联合MRI用于子宫内膜癌分期诊断的临床价值。方法以我院影像科收治的36例经病理证实的子宫内膜癌患者为研究对象,根据其临床资料进行回顾性分析和总结,分别对其进行单纯CT、MRI检查以及CT联合MRI检查,以病理诊断为依据,对比分析其诊断结果。结果单纯CT分期诊断的准确率为55.6%,单纯MRI分期诊断的准确率为66.7%,CT联合MRI分期诊断的准确率为88.9%,CT联合MRI检查的准确率明显高于单纯CT或MRI,P<0.05,具有统计学意义。结论 CT联合MRI用于子宫内膜癌分期诊断具有较高的临床价值,与单纯的CT或MRI检查相比,其诊断准确率更高,可以为患者后续治疗提供重要的参考依据,具有较高的临床应用价值,值得推广。

Objective To evaluate clinical value CT in combination with Magnetic Resonance Imaging（MRI） for staging diagnosis of endometrial carcinoma. MethodsThirty sixty patients admitted by the Video branch of the Hospital confirmed to suffer from endometrial carcinoma via were selected as the research candidates, who were retrospectively analyzed and summarized according to the clinical data, and such candidates were subject to single MRI and CT examination and combined examination of MRI and CT respectively, and diagnostic results were compared and analyzed based on pathological diagnosis. Results The staging diagnosis accuracy of single CT hit 55.6% pure, that value for pure MRI and combined CT and MRI hit 66.7% and 88.9% respectively, the accuracy of CT in combination with MRI was obviously higher than that of pure CT or MRI（P〈0.05）, the differences had statistical significance. ConclusionsThe staging diagnosis of CT combined with MRI on endometrial carcinoma delivers high clinical value, and its diagnosis accuracy is higher when compared to pure CT or MRI, it may provide important reference basis for treatments in the future, imposing high clinical value and being worthy of promotion.